4//SEC Filing
Eansor Norman David 4
Accession 0001104659-25-014317
CIK 0001094038other
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 5:18 PM ET
Size
6.2 KB
Accession
0001104659-25-014317
Insider Transaction Report
Form 4
EANSOR N DAVID
Director
Transactions
- Award
Stock Option (right to buy)
2025-02-12+30,000→ 30,000 totalExercise: $1.59Exp: 2035-02-12→ Common Stock (30,000 underlying)
Footnotes (1)
- [F1]Represents options granted under the Company's 2020 Omnibus Stock Ownership Plan. One third of the shares vest on the first anniversary of the grant date and the remainder of the shares subsequently vest in equal annual installments over the second and third anniversary of the grant date subject to the Reporting Person's continued service as a director. The option exercise price is the closing price on the date of the grant, February 12, 2025.
Documents
Issuer
Marker Therapeutics, Inc.
CIK 0001094038
Entity typeother
Related Parties
1- filerCIK 0001270905
Filing Metadata
- Form type
- 4
- Filed
- Feb 13, 7:00 PM ET
- Accepted
- Feb 14, 5:18 PM ET
- Size
- 6.2 KB